C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 114 filers reported holding C4 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $88,268 | -33.2% | 47,456 | -1.2% | 0.02% | -30.4% |
Q2 2023 | $132,129 | -12.4% | 48,047 | 0.0% | 0.02% | -14.8% |
Q1 2023 | $150,868 | -2.7% | 48,047 | +82.8% | 0.03% | 0.0% |
Q4 2022 | $155,117 | -17.9% | 26,291 | +21.7% | 0.03% | -25.0% |
Q3 2022 | $189,000 | +22.7% | 21,601 | +5.9% | 0.04% | +33.3% |
Q2 2022 | $154,000 | – | 20,398 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |